Log in to save to my catalogue

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Child...

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Child...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3491735

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

About this item

Full title

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Publisher

Oxford: Oxford University Press

Journal title

The Journal of infectious diseases, 2012-08, Vol.206 (4), p.512-522

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Background. Response rates and immunologic memory following measles vaccination are reduced in human immunodeficiency virus (HIV)—infected children in the absence of highly active antiretroviral therapy (HAART). Methods. HIV-infected children 2 to <19 years old receiving HAART and with HIV loads <30 000 copies/cL, CD4% ≥15, and ≥1 prior measles-mum...

Alternative Titles

Full title

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3491735

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3491735

Other Identifiers

ISSN

0022-1899

E-ISSN

1537-6613

DOI

10.1093/infdis/jis386

How to access this item